Clinical Report

Acute Liver Failure of Preterm Infant

  • Lin ZHOU ,
  • Chengbo LIU ,
  • Ming LIU ,
  • Yunkai ZHU ,
  • Yongjian LU ,
  • Yongjun ZHANG ,
  • Hongping XIA
Expand
  • 1. Department of Neonatology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    2. Department of Radiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    3. Department of Ultrasonography, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    4. Department of Stomatology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received date: 2022-10-24

  Online published: 2024-02-02

Abstract

Objective To investigate the clinical features of gestational alloimmune liver disease-neonatal hemochromatosis (GALD-NH) and to provide differential diagnosis of neonatal liver failure.Method A preterm infant admitted in neonatal intensive care unit shortly after birth. He presented with persistent thrombocytopenia, severe coagulation disorder, hypoproteinemia, cholestasis and ascites. Specialists from Department of Radiology, Ultrasonography, and Stomatology were invited to discuss the case. The diagnosis and treatment were adjusted according to the result of discussion. Results The case was characterized by acute liver failure in the early life. After multi-disciplinary treatment, GALD-NH was considered as the most likely cause of liver failure. Although oral mucosa biopsy was negative, abdominal (liver, spleen, pancreas) MRI showed liver and spleen had hypointense on T2WI. Liver biopsy showed that pathologic siderosis in hepatocytes. The patient finally diagnosed as GALD-NH. Conclusion When neonate with liver failure, neonatal hemochromatosis should be considered in addition to infectious liver disease, obstructive liver disease and genetic metabolic disease.

Cite this article

Lin ZHOU , Chengbo LIU , Ming LIU , Yunkai ZHU , Yongjian LU , Yongjun ZHANG , Hongping XIA . Acute Liver Failure of Preterm Infant[J]. Journal of Clinical Pediatrics, 2024 , 42(2) : 151 -156 . DOI: 10.12372/jcp.2024.22e1420

References

[1] 覃小梅, 李双杰. 新生儿急性肝衰竭的病因、诊断及治疗[J]. 临床肝胆病杂志, 2022, 38(2): 260-263.
[2] Laurendeau T, Hill JE, Manning GB. Idiopathic neonatal hemochromatosis in siblings. An inborn error of metabolism[J]. Arch Pathol, 1961, 72: 410-423.
[3] Pan X, Kelly S, Melin-Aldana H, et al. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade[J]. Hepatology, 2010, 51(6): 2061-2068.
[4] Whitington PF. Fetal and infantile hemochromatosis[J]. Hepatology, 2006, 43(4): 654-660.
[5] Whitington PF. Gestational alloimmune liver disease and neonatal hemochromatosis[J]. Semin Liver Dis, 2012, 32(4): 325-332.
[6] Casas-Alba D, Clotet J, Inarejos EJ, et al. Broadening the spectrum of neonatal hemochromatosis[J]. J Matern Fetal Neonatal Med, 2020, 33(6): 1024-1026.
[7] Feldman AG, Whitington PF. Neonatal hemochromatosis[J]. J Clin Exp Hepatol, 2013, 3(4): 313-320.
[8] Roos Mariano da Rocha C, Rostirola Guedes R, Kieling CO, et al. Neonatal liver failure and congenital cirrhosis due to gestational alloimmune liver disease: a case report and literature review[J]. Case Rep Pediatr, 2017: 7432859.
[9] 王晗, 陈莲. 新生儿血色病1例报道[J]. 诊断病理学杂志, 2021, 28(7): 579-581.
[10] Taylor SA, Whitington PF. Neonatal acute liver failure[J]. Liver Transpl, 2016, 22(5): 677-685.
[11] 朱菊盼, 杨全新, 闫锐. 同胞家系新生儿血色病2例及文献复习[J]. 实用放射学杂志, 2022, 38(2): 342.
[12] Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis[J]. Semin Liver Dis, 2007, 27(3): 243-250.
[13] Rand EB, Karpen SJ, Kelly S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin[J]. J Pediatr, 2009, 155(4): 566-571.
[14] Heffron T, Pillen T, Welch D, et al. Medical and surgical treatment of neonatal hemochromatosis: single center experience[J]. Pediatr Transplant, 2007, 11(4): 374-378.
[15] Park GY, Song JI, Lee SH, et al. Gestational alloimmune liver disease treated with exchange transfusion and intravenous immunoglobulin: a case study[J]. Transfus Apher Sci, 2022, 61(3): 103347.
[16] Yeh PJ, Huang SF, Chiang MC, et al. Efficacy of intravenous immunoglobulin/exchange transfusion therapy on gestational alloimmune liver disease[J]. Front Pediatr, 2021, 9: 680730.
[17] Timpani G, Foti F, Nicolò A, et al. Is exchange transfusion a possible treatment for neonatal hemochromatosis?[J]. J Hepatol, 2007, 47(5): 732-735.
[18] 陶莉. 妊娠同族免疫性肝病及新生儿血色病[J]. 国际儿科学杂志, 2018, 45(4): 291-294.
[19] Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin[J]. Pediatrics, 2008, 121(6): e1615-e1621.
[20] Whitington PF, Kelly S, Taylor SA, et al. Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation[J]. Fetal Diagn Ther, 2018, 43(3): 218-225.
Outlines

/